GAS5 (growth arrest-specific 5) was found to have lower expression in IPMN cases compared to controls (p = 0.028), consistent with data33 showing that GAS5 expression is significantly decreased in pancreatic cancer tissues compared with normal pancreatic tissues. The gene discussed is GAS5; the disease is pancreatic neoplasm.